Targeting bacterial central metabolism for drug development

Chemistry & Biology
Paul MurimaKevin Pethe

Abstract

Current antibiotics, derived mainly from natural sources, inhibit a narrow spectrum of cellular processes, namely DNA replication, protein synthesis, and cell wall biosynthesis. With the worldwide explosion of drug resistance, there is renewed interest in the investigation of alternate essential cellular processes, including bacterial central metabolic pathways, as a drug target space for the next generation of antibiotics. However, the validation of targets in central metabolism is more complex, as essentiality of such targets can be conditional and/or contextual. Bearing in mind our enhanced understanding of prokaryotic central metabolism, a key question arises: can central metabolism be bacteria's Achilles' heel and a therapeutic target for the development of new classes of antibiotics? In this review, we draw lessons from oncology and attempt to address some of the open questions related to feasibility of targeting bacterial central metabolism as a strategy for developing new antibacterial drugs.

References

Feb 13, 2016·Scientific Reports·Hongkai BiJohn E Cronan
Apr 8, 2015·Proceedings of the National Academy of Sciences of the United States of America·Samuel A LeeColin Manoil
Jun 24, 2015·Annals of the New York Academy of Sciences·Maya A Farha, Eric D Brown
Mar 18, 2016·Expert Opinion on Therapeutic Patents·Meng ZhangRong Shao
Apr 20, 2016·Frontiers in Microbiology·Guyue ChengZonghui Yuan
May 20, 2016·Omics : a Journal of Integrative Biology·Shashwat Deepali NagarSonika Bhatnagar
Sep 7, 2016·Frontiers in Microbiology·Yee-Chin WongSheila Nathan
Aug 25, 2016·Nature Communications·Paul MurimaJohn D McKinney
Jan 26, 2016·Natural Product Reports·Maya A Farha, Eric D Brown
Jul 4, 2017·Nature Chemical Biology·Samantha WellingtonDeborah T Hung
Feb 16, 2018·Oxidative Medicine and Cellular Longevity·Laurence VernisMeng-Er Huang
May 4, 2018·The Journal of Biological Chemistry·Asma U HusnaRichard A Strugnell
Aug 12, 2015·Archives of Pharmacal Research·Michelle Lay Teng AngKevin Pethe
Apr 30, 2017·Applied and Environmental Microbiology·Troy E SandbergAdam M Feist
Nov 30, 2018·Journal of Biomolecular Structure & Dynamics·Kelath Murali ManojSurjith Ramasamy
Aug 19, 2017·Nature Chemical Biology·William R Bishai
Mar 3, 2019·Applied and Environmental Microbiology·A JochimS Heilbronner
Apr 20, 2019·Drug Metabolism Reviews·Paul Andrei TentMihai Juncar
Mar 8, 2017·Proceedings of the National Academy of Sciences of the United States of America·Susan PuckettSabine Ehrt
Jun 17, 2020·PLoS Computational Biology·Víctor A López-AgudeloRigoberto Rios-Estepa
May 18, 2018·PloS One·Sara SandersCaren L Freel Meyers
Mar 11, 2018·Biochemistry. Biokhimii︠a︡·E Yu BezsudnovaV O Popov
May 13, 2018·The Journal of Biological Chemistry·Bhavya JhaBichitra Kumar Biswal

Citations

Jun 1, 1973·Journal of General Microbiology·R Then, P Angehrn
May 1, 1968·British Journal of Pharmacology and Chemotherapy·S R Bushby, G H Hitchings
Aug 1, 1994·Journal of Veterinary Pharmacology and Therapeutics·A S van Miert
Feb 9, 2002·Current Opinion in Microbiology·Christopher Sassetti, Eric J Rubin
May 1, 2002·Nature Biotechnology·Joseph A DeVitoDavid L Pompliano
Sep 5, 2002·Nature Reviews. Drug Discovery·Andrew L Hopkins, Colin R Groom
Sep 4, 2003·The Journal of Experimental Medicine·Dirk SchnappingerGary K Schoolnik
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Juliano TimmJohn D McKinney
Dec 20, 2003·Pharmacogenomics·Dezhong YinYinduo Ji
May 26, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Helene PelicanoPeng Huang
Jul 17, 2004·Science·Neil P ShahCharles L Sawyers
Aug 17, 2004·Science·Nathalie Q BalabanStanislas Leibler
Nov 20, 2004·Nature Reviews. Microbiology·Ulrich E Schaible, Stefan H E Kaufmann
May 17, 2005·Nature Medicine·Ernesto J Muñoz-Elías, John D McKinney
Jul 23, 2005·IUBMB Life·T N C RamyaAvadhesha Surolia
Oct 12, 2005·Archives of Medical Research·Alfonso J Alanis
Dec 20, 2005·Biochemical Pharmacology·Stephen HawserKhalid Islam
Dec 22, 2005·Cellular Microbiology·Ernesto J Muñoz-Elías, John D McKinney
Jan 21, 2006·Science·Vanessa M D'CostaGerard D Wright
Jun 23, 2006·PLoS Computational Biology·Samiul HasanMark Schreiber
Aug 5, 2006·Nature Reviews. Drug Discovery·Robert A CopelandThomas D Meek
Dec 13, 2006·Nature Reviews. Drug Discovery·David J PayneDavid L Pompliano
Dec 19, 2006·PLoS Pathogens·Joshua MungerJoshua D Rabinowitz
May 15, 2007·Nature Chemical Biology·Anil KoulKoen Andries
Feb 16, 2008·Science·Brian D CorbinEric P Skaar
Aug 6, 2008·Nature Reviews. Microbiology·Stacie A BrownMarvin Whiteley
Aug 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Srinivasa P S RaoKevin Pethe
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Dec 17, 2008·Antimicrobial Agents and Chemotherapy·Anna C HaagsmaDirk Bald
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·J Richard MillerC Kendall Stover
Feb 28, 2009·Current Opinion in Cell Biology·Mark SchreiberAlex Matter
May 23, 2009·Science·Matthew G Vander HeidenCraig B Thompson
May 30, 2009·Nature Reviews. Drug Discovery·Dunyaporn TrachoothamPeng Huang
Jun 30, 2009·Nature Chemical Biology·Bryson D BennettJoshua D Rabinowitz
Aug 29, 2009·Science·Michael A Fischbach, Christopher T Walsh

Related Concepts

Metabolic Process, Cellular
Tumor Cells, Uncertain Whether Benign or Malignant
Central Nervous System Bacterial Infections
Biochemical Pathway
Fructose
Gluconeogenesis
Enzymes, antithrombotic
Metabolic Networks
Metabolic Networks and Pathways
Aminoglycosides

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

ATP Synthases

ATP synthases are enzymes located in the inner mitochondrial membrane that catalyze the synthesis of ATP during cellular respiration. Discover the latest research on ATP synthases here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Current Opinion in Investigational Drugs
Sohail T AliAnn Lewendon
The Journal of Bone and Joint Surgery. American Volume
D B Kettelkamp
International Journal of Medical Microbiology : IJMM
Tanja Schneider, Hans-Georg Sahl
© 2020 Meta ULC. All rights reserved